Work

ALL-471: Remission-Survival Discordance With Blinatumomab in Relapsed/Refractory Acute Lymphoblastic Leukemia: A Propensity-Matched Real-World Analysis

Year: 2026

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(26)01660-5

Authors: Malik Abubakar, Sindhu Chadalawada, Preetham Ezhilarasu, Alsu Ramazanova, Abyot Teshome, Tanzina Nowrin, Balqees Ara, Abhishek Kumar

Institutions: Capital Health, Albert Einstein College of Medicine, Jacobi Medical Center

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7204719085

Cites:

Cited by:

Related to: